What Laboratoires Expanscience does

Laboratoires Expanscience is a family-owned, independent French pharmaceutical and dermo-cosmetics laboratory founded in 1950 and headquartered at Paris La Défense, with manufacturing operations at Epernon, France. The company operates across four business segments: consumer dermo-cosmetics (Mustela flagship brand for baby and family skincare, Babo Botanicals, and Iana anti-aging), prescription rheumatology (Piascledine 300 based on avocado and soy unsaponifiables, Hyalexo hyaluronic acid injections, VitaliTENS/ActiTENS devices, Nabucox, Flexea, Takadol), prescription dermatology (Effizinc, Doxylis, Procuta), and B2B natural cosmetic and nutraceutical active ingredients, with wholly-owned subsidiaries in 11 countries spanning Europe, the Americas, and Australia.

The portfolio rests on natural-origin ingredient expertise combined with pharmaceutical formulation technology. Piascledine 300, the proprietary rheumatology medication, is differentiated by its avocado and soy unsaponifiable active; the Hyalexo range spans mono-, cross-linked, and tri-injection formulations; and TENS-based pain management devices (VitaliTENS, ActiTENS mini) extend the therapeutic footprint. In May 2025, Expanscience launched Tulsinity Bio, its first nutraceutical active ingredient, entering the nutraceuticals B2B market. The company has committed to sourcing 50% of raw materials regeneratively by 2035 through multi-year farmer contracts, and operates under B Corp certification, Great Place to Work certification (France 2025-2026), Société à Mission status, and ISO 14001.

Expanscience generates revenue through prescription pharmaceutical sales, OTC dermo-cosmetic sales, medical devices, and B2B ingredient licensing. Distribution is anchored in pharmacy channels, where it holds a 49.5% market share in certain categories, complemented by retail and direct-to-manufacturer B2B ingredient supply. Pricing is not publicly disclosed. The 2025 Phase 2 rollout of Pharma-Recharge signals investment in pharmacy-based refill infrastructure as a recurring-revenue channel. Revenue figures are not publicly disclosed; the company is privately held with no parent company, institutional investors, or external funding rounds identified.

Name

Laboratoires Expanscience

Legal name

Laboratoires Expanscience

Website

https://expanscience.com

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Laboratoires Expanscience is a family-owned French pharmaceutical and dermo-cosmetics laboratory founded in 1950, operating across consumer skincare (Mustela, Babo Botanicals, Iana), prescription rheumatology and dermatology, and B2B natural active ingredients, with subsidiaries in 11 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Dermo-Cosmetics

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Sensitive Skin & Barrier Repair (CRABAAAG), Dermatology Specialty Pharmaceuticals (HLAIACAL), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Dermo-cosmetic products
• Pharmaceutical medications
• Baby skincare products
• Rheumatology treatments
• Natural cosmetic ingredients

Headquarters

HQ city

La Défense

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

1. Dermo-cosmetics: Sale of dermo-cosmetic products including the flagship Mustela brand for baby and family skincare, as well as Babo Botanicals. Products are distributed through pharmacies and retail channels.
2. Dermatology: Sale of dermatological medications including Effizinc, Doxylis GE, and Procuta for various skin conditions.
3. Rheumatology & Osteoarthritis: Sale of rheumatology medications including Piascledine 300 (avocado/soy unsaponifiables), Hyalexo products (injections), Flexea, Nabucox, and Takadol for osteoarthritis and pain management.
4. Cosmetic and Nutraceutical Actives: Supply of natural ingredients and active ingredients to the cosmetics industry, including the new Tulsinity Bio nutraceutical ingredient launched in May 2025.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Laboratoires Expanscience develops, manufactures, and sells pharmaceutical medications and dermo-cosmetic products across four segments: (1) dermo-cosmetics for baby, family and anti-aging skincare (Mustela, Babo Botanicals, Iana brands), (2) rheumatology and osteoarthritis treatments including Piascledine 300 medication, hyaluronic acid injections, and TENS pain devices, (3) dermatology medications for skin conditions, and (4) natural cosmetic and nutraceutical active ingredients supplied to cosmetics manufacturers, including the newly launched Tulsinity Bio ingredient.

Product overview

Laboratoires Expanscience is a family-owned, independent pharmaceutical and dermo-cosmetics group operating across four main segments: dermo-cosmetics (skincare for the whole family via Mustela and Babo Botanicals), rheumatology/arthritis (including Piascledine 300 medication, VitaliTENS/ActiTENS devices, Hyalexo hyaluronic acid injections, and oral medications like Nabucox, Flexea, and Takadol), dermatology (Effizinc, Doxylis, Procuta), and natural cosmetic/nutraceutical ingredients for industry (including newly launched Tulsinity Bio). The company also offers Iana for the first signs of aging. The portfolio ranges from consumer-facing skincare brands to prescription pharmaceuticals and industrial ingredient supplies.

Differentiator

Problem solved

Functional benefit

Brands

• Mustela: Flagship brand for natural origin skincare for the whole family, from birth.
• Piascledine 300
• Babo Botanicals
• Iana
• Tulsinity Bio
• Effizinc
• Doxylis
• Procuta
• VitaliTENS
• ActiTENS mini
• Hyalexo TRI
• Hyalexo CROSS
• Hyalexo MONO
• Flexea
• Nabucox
• Takadol

Products and services

• Mustela Flagship brand for natural-origin skincare products for the entire family from birth, covering baby care, maternity, and general skincare. Distributed through pharmacies and retail channels.
• Piascledine 300 Medication based on unsaponifiables of avocado and soybean dedicated to rheumatology and osteoarthritis treatment. Proprietary pharmaceutical formulation.
• Iana Product line targeting first signs of aging, focused on helping individuals build their well-being with age.
• Babo Botanicals
• Effizinc Dermatology medication for skin treatment, including zinc deficiency-related dermatological conditions.
• Doxylis GE Dermatology medication.
• Procuta GE Dermatology medication used for acne treatment.
• VitaliTENS TENS (Transcutaneous Electrical Nerve Stimulation) device for pain management in rheumatology.
• ActiTENS mini Compact TENS device for targeted pain relief in rheumatology patients.
• Hyalexo TRI Hyaluronic acid injection for rheumatology, cross-linked formulation.
• Hyalexo CROSS Hyaluronic acid injection for rheumatology, cross-linked formulation.
• Hyalexo MONO Hyaluronic acid injection for rheumatology, monodose formulation.
• Flexea Rheumatology treatment product.
• Nabucox Anti-inflammatory medication for rheumatology available in 500mg and 1g dosages.
• Takadol Pain management medication for rheumatology.
• Tulsinity Bio Nutraceutical active ingredient for the cosmetics and nutraceutical industry, supplied to manufacturers as a B2B ingredient.
• Pharma-Recharge (Phase 2) Refill/recharge program for pharmaceutical products distributed through pharmacies, supporting sustainable packaging initiatives.

Quantifiable outcome

• 50% of raw materials to be sourced regeneratively by 2035
• +1 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Pierre Fabre Group: French, family-owned pharmaceutical and dermo-cosmetics group operating Avène, A-Derma, Klorane, and Dexeryl in pharmacy channels across Europe and internationally. Direct comparable on dermo-cosmetics portfolio, pharmacy distribution, and family-owned pharma-lab structure.
• Galderma: Switzerland-based dermatology-focused pharma and dermo-cosmetics company spanning prescription dermatology, therapeutic skincare, and aesthetic injectables. Directly comparable therapeutic dermatology and consumer skincare overlap with Expanscience's dermatology and Mustela-style offerings.
• NAOS (Bioderma, Institut Esthederm, Etat Pur): French family-owned dermo-cosmetics group built around Bioderma and Institut Esthederm in pharmacy channels globally. Comparable in dermo-cosmetics, pharmacy-led GTM, family-owned independent structure, and European heritage.
• Laboratoires Dermatologiques d'Uriage: French dermo-cosmetics brand owned by Puig, sold through pharmacies and dermatologists for sensitive and atopic skin. Closely comparable to Mustela on pharmacy-led sensitive-skin positioning.
• Laboratoires Boiron: French family-controlled homeopathic and OTC pharmaceutical laboratory distributing through pharmacies across Europe and the US. Comparable as a family-owned French pharma/OTC laboratory with a pharmacy channel focus.
• Weleda: Swiss-German natural dermo-cosmetics and anthroposophic medicine company with natural-origin baby care, skincare, and B2B ingredient heritage. Comparable on natural-origin positioning, baby/family skincare (Calendula vs. Mustela), and B2B ingredient business.

Broad incumbents

• L'Oréal Dermatological Beauty Division: Division of L'Oréal housing La Roche-Posay, Vichy, Cerave, and SkinCeuticals, dominating dermo-cosmetics globally. Overlaps directly with Expanscience's dermo-cosmetics franchise but at vastly larger scale, broader geography, and marketing intensity.
• Johnson & Johnson Consumer Health (Kenvue): Now-independent Kenvue houses Aveeno, Johnson's Baby, and Neutrogena, directly competing with Mustela in baby/family skincare. A broad incumbent with comparable baby skincare positioning and global distribution.

Others

• Croda International: UK-listed specialty chemicals and personal care ingredients supplier serving cosmetics and pharma customers with natural and sustainable actives. Comparable to Expanscience's B2B natural cosmetic/nutraceutical ingredients business (including Tulsinity Bio).
• Symrise: German specialty ingredients supplier for cosmetics, personal care, and nutrition with a strong naturals platform. Comparable as an enabler/B2B counterpart to Expanscience's cosmetic and nutraceutical active ingredients franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/expanscience
• LinkedInlinkedin.com/company/laboratoires-expanscience

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoires Expanscience